(Q40471170)

20 September 2017

title

The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone. (English)

1 reference

20 September 2017

4

Chikako Shimizu

1 reference

20 September 2017

5

Masashi Ando

1 reference

20 September 2017

2

Noriyuki Katsumata

1 reference

20 September 2017

Toshiro Mizuno

1

1 reference

20 September 2017

Hirofumi Mukai

series ordinal

3

1 reference

20 September 2017

Toru Watanabe

series ordinal

6

1 reference

20 September 2017

language of work or name

1 reference

29 August 2006

1 reference

Supportive Care in Cancer

20 September 2017

published in

1 reference

20 September 2017

volume

15

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

287-291

1 reference

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy

20 September 2017

cites work

1 reference

12 December 2020

Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer

1 reference

12 December 2020

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

12 December 2020

Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule

1 reference

12 December 2020

Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

1 reference

12 December 2020

Infections caused by viridans streptococci in patients with neutropenia

1 reference

12 December 2020

The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation

1 reference

12 December 2020

Docetaxel in combination with doxorubicin: a phase I dose-finding study

1 reference

12 December 2020

Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.

1 reference

12 December 2020

New trends in patient management: risk-based therapy for febrile patients with neutropenia

1 reference

12 December 2020

Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths

1 reference

12 December 2020

Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients.

1 reference

12 December 2020

Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

1 reference

12 December 2020

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

1 reference

12 December 2020

Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients

1 reference

12 December 2020

Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196

1 reference

12 December 2020

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

1 reference

12 December 2020

10.1007/S00520-006-0126-6

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1049341538

0 references

1 reference